November 23, 2024 19:08 (IST)
Cinacalcet tablets case: Cipla, Amgen settle legal dispute
Mumbai/UNI: Pharma major, Cipla on Monday said company has settled a a legal dispute with Amgen in the United States involving generic cinacalcet hydrochloride tablets , used in treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease.
Latest Headlines
Cinacalcet tablets case: Cipla, Amgen settle legal dispute Mon, Jul 20 2020